TY - JOUR AU - Nielsen, T. O. AU - Hsu, F. D. AU - Jensen, K. AU - Cheang, M. AU - Karaca, G. AU - Hu, Z. PY - 2004 DA - 2004// TI - Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma immunohistochemical and clinical characterization of the basal- like subtype of invasive breast carcinoma JO - Clin Cancer Res VL - 10 UR - https://doi.org/10.1158/1078-0432.CCR-04-0220 DO - 10.1158/1078-0432.CCR-04-0220 ID - Nielsen2004 ER - TY - JOUR AU - Sørlie, T. AU - Perou, C. M. AU - Tibshirani, R. AU - Aas, T. AU - Geisler, S. AU - Johnsen, H. PY - 2001 DA - 2001// TI - Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications JO - Proc Natl Acad Sci U S A VL - 98 UR - https://doi.org/10.1073/pnas.191367098 DO - 10.1073/pnas.191367098 ID - Sørlie2001 ER - TY - JOUR AU - Bertucci, F. AU - Finetti, P. AU - Cervera, N. AU - Esterni, B. AU - Hermitte, F. AU - Viens, P. PY - 2008 DA - 2008// TI - How basal are triple-negative breast cancers? JO - Int J Cancer VL - 123 UR - https://doi.org/10.1002/ijc.23518 DO - 10.1002/ijc.23518 ID - Bertucci2008 ER - TY - STD TI - Grinde MT, Skrbo N, Moestue SA, Rødland EA, Borgan E, Kristian A, et al. Interplay of choline metabolites and genes in patient-derived breast cancer xenografts. Breast Cancer Res. 2014;16:R5. ID - ref4 ER - TY - STD TI - Moestue S a, Borgan E, Huuse EM, Lindholm EM, Sitter B, Børresen-Dale A-L, et al. Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models. BMC Cancer. 2010;10. ID - ref5 ER - TY - JOUR AU - Nakanishi, M. AU - Rosenberg, D. W. PY - 2006 DA - 2006// TI - Roles of cPLA2alpha and arachidonic acid in cancer JO - Biochim Biophys Acta VL - 1761 UR - https://doi.org/10.1016/j.bbalip.2006.09.005 DO - 10.1016/j.bbalip.2006.09.005 ID - Nakanishi2006 ER - TY - JOUR AU - Wen, Z. -. H. AU - Su, Y. -. C. AU - Lai, P. -. L. AU - Zhang, Y. AU - Xu, Y. -. F. AU - Zhao, A. PY - 2013 DA - 2013// TI - Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis JO - Oncogene VL - 32 UR - https://doi.org/10.1038/onc.2012.47 DO - 10.1038/onc.2012.47 ID - Wen2013 ER - TY - JOUR AU - Patel, M. I. AU - Singh, J. AU - Niknami, M. AU - Kurek, C. AU - Yao, M. AU - Lu, S. PY - 2008 DA - 2008// TI - Cytosolic phospholipase A2-alpha: a potential therapeutic target for prostate cancer JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-08-0566 DO - 10.1158/1078-0432.CCR-08-0566 ID - Patel2008 ER - TY - JOUR AU - Linkous, A. AU - Geng, L. AU - Lyshchik, A. AU - Hallahan, D. E. AU - Yazlovitskaya, E. M. PY - 2009 DA - 2009// TI - Cytosolic phospholipase A2: targeting cancer through the tumor vasculature JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-1905 DO - 10.1158/1078-0432.CCR-08-1905 ID - Linkous2009 ER - TY - JOUR AU - Cai, Q. AU - Zhao, Z. AU - Antalis, C. AU - Yan, L. AU - Priore, G. AU - Hamed, A. H. PY - 2012 DA - 2012// TI - Elevated and secreted phospholipase A2 activities as new potential therapeutic targets in human epithelial ovarian cancer JO - FASEB J VL - 26 UR - https://doi.org/10.1096/fj.12-207597 DO - 10.1096/fj.12-207597 ID - Cai2012 ER - TY - JOUR AU - Thotala, D. AU - Craft, J. M. AU - Ferraro, D. J. AU - Kotipatruni, R. P. AU - Bhave, S. R. AU - Jaboin, J. J. PY - 2013 DA - 2013// TI - Cytosolic phospholipaseA2 inhibition with PLA-695 radiosensitizes tumors in lung cancer animal models JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0069688 DO - 10.1371/journal.pone.0069688 ID - Thotala2013 ER - TY - JOUR AU - Ghosh, M. AU - Tucker, D. E. AU - Burchett, S. A. AU - Leslie, C. C. PY - 2006 DA - 2006// TI - Properties of the group IV phospholipase A2 family JO - Prog Lipid Res VL - 45 UR - https://doi.org/10.1016/j.plipres.2006.05.003 DO - 10.1016/j.plipres.2006.05.003 ID - Ghosh2006 ER - TY - JOUR AU - Yazlovitskaya, E. M. AU - Linkous, A. G. AU - Thotala, D. K. AU - Cuneo, K. C. AU - Hallahan, D. E. PY - 2008 DA - 2008// TI - Cytosolic phospholipase A2 regulates viability of irradiated vascular endothelium JO - Cell Death Differ VL - 15 UR - https://doi.org/10.1038/cdd.2008.93 DO - 10.1038/cdd.2008.93 ID - Yazlovitskaya2008 ER - TY - JOUR AU - Linkous, A. G. AU - Yazlovitskaya, E. M. AU - Hallahan, D. E. PY - 2010 DA - 2010// TI - Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis JO - J Natl Cancer Inst VL - 102 UR - https://doi.org/10.1093/jnci/djq290 DO - 10.1093/jnci/djq290 ID - Linkous2010 ER - TY - STD TI - Fujita Y, Yoshizumi M, Izawa Y, Ali N, Ohnishi H, Kanematsu Y, et al. Transactivation of fetal liver kinase-1/kinase-insert domain-containing receptor by lysophosphatidylcholine induces vascular endothelial cell proliferation. Endocrinology. 2006;147:1377–85. ID - ref15 ER - TY - JOUR AU - Wang, D. AU - Dubois, R. N. PY - 2010 DA - 2010// TI - Eicosanoids and cancer JO - Nat Rev Cancer VL - 10 UR - https://doi.org/10.1038/nrc2809 DO - 10.1038/nrc2809 ID - Wang2010 ER - TY - JOUR AU - Greenhough, A. AU - Smartt, H. J. M. AU - Moore, A. E. AU - Roberts, H. R. AU - Williams, A. C. AU - Paraskeva, C. PY - 2009 DA - 2009// TI - The COX-2/PGE2 pathway: Key roles in the hallmarks of cancer and adaptation to the tumour microenvironment JO - Carcinogenesis VL - 30 UR - https://doi.org/10.1093/carcin/bgp014 DO - 10.1093/carcin/bgp014 ID - Greenhough2009 ER - TY - JOUR AU - Chen, E. P. AU - Smyth, E. M. PY - 2011 DA - 2011// TI - COX-2 and PGE2-dependent immunomodulation in breast cancer JO - Prostaglandins Other Lipid Mediat VL - 96 UR - https://doi.org/10.1016/j.prostaglandins.2011.08.005 DO - 10.1016/j.prostaglandins.2011.08.005 ID - Chen2011 ER - TY - JOUR AU - Timoshenko, A. V. AU - Xu, G. AU - Chakrabarti, S. AU - Lala, P. K. AU - Chakraborty, C. PY - 2003 DA - 2003// TI - Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells JO - Exp Cell Res VL - 289 UR - https://doi.org/10.1016/S0014-4827(03)00269-6 DO - 10.1016/S0014-4827(03)00269-6 ID - Timoshenko2003 ER - TY - JOUR AU - Chang, S. -. H. AU - Liu, C. H. AU - Conway, R. AU - Han, D. K. AU - Nithipatikom, K. AU - Trifan, O. C. PY - 2004 DA - 2004// TI - Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression JO - Proc Natl Acad Sci U S A VL - 101 UR - https://doi.org/10.1073/pnas.2535911100 DO - 10.1073/pnas.2535911100 ID - Chang2004 ER - TY - JOUR AU - Bergamaschi, A. AU - Hjortland, G. O. AU - Triulzi, T. AU - Sørlie, T. AU - Johnsen, H. AU - Ree, A. H. PY - 2009 DA - 2009// TI - Molecular profiling and characterization of luminal-like and basal-like in vivo breast cancer xenograft models JO - Mol Oncol VL - 3 UR - https://doi.org/10.1016/j.molonc.2009.07.003 DO - 10.1016/j.molonc.2009.07.003 ID - Bergamaschi2009 ER - TY - JOUR AU - Kokotos, G. AU - Feuerherm, A. J. AU - Barbayianni, E. AU - Shah, I. AU - Sæther, M. AU - Magrioti, V. PY - 2014 DA - 2014// TI - Inhibition of group IVA cytosolic phospholipase A2 by thiazolyl ketones in vitro, ex vivo, and in vivo JO - J Med Chem VL - 57 UR - https://doi.org/10.1021/jm500192s DO - 10.1021/jm500192s ID - Kokotos2014 ER - TY - JOUR AU - Huuse, E. M. AU - Moestue, S. a. AU - Lindholm, E. M. AU - Bathen, T. F. AU - Nalwoga, H. AU - Krüger, K. PY - 2012 DA - 2012// TI - In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts JO - J Magn Reson Imaging VL - 35 UR - https://doi.org/10.1002/jmri.23507 DO - 10.1002/jmri.23507 ID - Huuse2012 ER - TY - CHAP AU - Wold, S. AU - Sjöström, M. AU - Eriksson, L. PY - 2001 DA - 2001// TI - PLS-regression: A basic tool of chemometrics BT - Chemometrics and Intelligent Laboratory Systems ID - Wold2001 ER - TY - JOUR AU - Chong, I. G. AU - Jun, C. H. PY - 2005 DA - 2005// TI - Performance of some variable selection methods when multicollinearity is present JO - Chemom Intell Lab Syst VL - 78 UR - https://doi.org/10.1016/j.chemolab.2004.12.011 DO - 10.1016/j.chemolab.2004.12.011 ID - Chong2005 ER - TY - STD TI - Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open source platform for biological image analysis. Nat Methods. 2012;9:676–82. ID - ref26 ER - TY - JOUR AU - Kim, E. AU - Cebulla, J. AU - Ward, B. D. AU - Rhie, K. AU - Zhang, J. AU - Pathak, A. P. PY - 2013 DA - 2013// TI - Assessing breast cancer angiogenesis in vivo: Which susceptibility contrast MRI biomarkers are relevant? JO - Magn Reson Med VL - 70 UR - https://doi.org/10.1002/mrm.24530 DO - 10.1002/mrm.24530 ID - Kim2013 ER - TY - STD TI - Westerhuis J a, Hoefsloot HCJ, Smit S, Vis DJ, Smilde AK, van Velzen EJJ, et al. Assessment of PLSDA cross validation. Metabolomics. 2008;4:81–9. ID - ref28 ER - TY - JOUR AU - Jagannathan, N. R. AU - Kumar, M. AU - Seenu, V. AU - Coshic, O. AU - Dwivedi, S. N. AU - Julka, P. K. PY - 2001 DA - 2001// TI - Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer JO - Br J Cancer VL - 84 UR - https://doi.org/10.1054/bjoc.2000.1711 DO - 10.1054/bjoc.2000.1711 ID - Jagannathan2001 ER - TY - JOUR AU - Lindholm, E. M. AU - Kristian, A. AU - Nalwoga, H. AU - Krüger, K. AU - Nygård, S. AU - Akslen, L. a. PY - 2012 DA - 2012// TI - Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal- and luminal-like breast cancer xenografts JO - Mol Oncol VL - 6 UR - https://doi.org/10.1016/j.molonc.2012.03.006 DO - 10.1016/j.molonc.2012.03.006 ID - Lindholm2012 ER - TY - JOUR AU - Carmeliet, P. AU - Jain, R. K. PY - 2011 DA - 2011// TI - Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases JO - Nat Rev Drug Discov VL - 10 UR - https://doi.org/10.1038/nrd3455 DO - 10.1038/nrd3455 ID - Carmeliet2011 ER - TY - JOUR AU - Moestue, S. a. AU - Huuse, E. M. AU - Lindholm, E. M. AU - Bofin, A. AU - Engebraaten, O. AU - Mælandsmo, G. M. PY - 2013 DA - 2013// TI - Low-molecular contrast agent dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted (DW)-MRI in early assessment of bevacizumab treatment in breast cancer xenografts JO - J Magn Reson Imaging VL - 38 UR - https://doi.org/10.1002/jmri.24079 DO - 10.1002/jmri.24079 ID - Moestue2013 ER - TY - JOUR AU - Emblem, K. E. AU - Farrar, C. T. AU - Gerstner, E. R. AU - Batchelor, T. T. AU - Borra, R. J. H. AU - Rosen, B. R. PY - 2014 DA - 2014// TI - Vessel calibre-a potential MRI biomarker of tumour response in clinical trials JO - Nat Rev Clin Oncol VL - 11 UR - https://doi.org/10.1038/nrclinonc.2014.126 DO - 10.1038/nrclinonc.2014.126 ID - Emblem2014 ER - TY - JOUR AU - Goel, S. AU - Duda, D. G. AU - Xu, L. AU - Munn, L. L. AU - Boucher, Y. AU - Fukumura, D. PY - 2011 DA - 2011// TI - Normalization of the vasculature for treatment of cancer and other diseases JO - Physiol Rev VL - 91 UR - https://doi.org/10.1152/physrev.00038.2010 DO - 10.1152/physrev.00038.2010 ID - Goel2011 ER - TY - JOUR AU - Armulik, A. AU - Genové, G. AU - Betsholtz, C. PY - 2011 DA - 2011// TI - Pericytes: Developmental, physiological, and pathological perspectives, problems, and promises JO - Dev Cell VL - 21 UR - https://doi.org/10.1016/j.devcel.2011.07.001 DO - 10.1016/j.devcel.2011.07.001 ID - Armulik2011 ER - TY - JOUR AU - Morikawa, S. AU - Baluk, P. AU - Kaidoh, T. AU - Haskell, A. AU - Jain, R. K. AU - McDonald, D. M. PY - 2002 DA - 2002// TI - Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors JO - Am J Pathol VL - 160 UR - https://doi.org/10.1016/S0002-9440(10)64920-6 DO - 10.1016/S0002-9440(10)64920-6 ID - Morikawa2002 ER - TY - JOUR AU - Dickson, P. V. AU - Hamner, J. B. AU - Sims, T. L. AU - Fraga, C. H. AU - Ng, C. Y. C. AU - Rajasekeran, S. PY - 2007 DA - 2007// TI - Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-07-0278 DO - 10.1158/1078-0432.CCR-07-0278 ID - Dickson2007 ER - TY - JOUR AU - Tong, R. T. AU - Boucher, Y. AU - Kozin, S. V. AU - Winkler, F. AU - Hicklin, D. J. AU - Jain, R. K. PY - 2004 DA - 2004// TI - Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-04-0074 DO - 10.1158/0008-5472.CAN-04-0074 ID - Tong2004 ER - TY - JOUR AU - Bhattacharya, A. AU - Seshadri, M. AU - Oven, S. D. AU - Tóth, K. AU - Vaughan, M. M. AU - Rustum, Y. M. PY - 2008 DA - 2008// TI - Tumor vascular maturation and improved drug delivery induced by methylselenocysteine leads to therapeutic synergy with anticancer drugs JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-08-0212 DO - 10.1158/1078-0432.CCR-08-0212 ID - Bhattacharya2008 ER - TY - JOUR AU - Tian, S. AU - Hayes, a. J. AU - Metheny-Barlow, L. J. AU - Li, L. -. Y. PY - 2002 DA - 2002// TI - Stabilization of breast cancer xenograft tumour neovasculature by angiopoietin-1 JO - Br J Cancer VL - 86 UR - https://doi.org/10.1038/sj.bjc.6600082 DO - 10.1038/sj.bjc.6600082 ID - Tian2002 ER - TY - JOUR AU - Ellis, L. M. AU - Hicklin, D. J. PY - 2009 DA - 2009// TI - Resistance to targeted therapies: Refining anticancer therapy in the era of molecular oncology JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-09-1070 DO - 10.1158/1078-0432.CCR-09-1070 ID - Ellis2009 ER -